These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34205021)

  • 1. A Systematic Review on the Role of SIRT1 in Duchenne Muscular Dystrophy.
    Domi E; Hoxha M; Prendi E; Zappacosta B
    Cells; 2021 Jun; 10(6):. PubMed ID: 34205021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
    Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
    J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.
    Krishnan SM; Nordlohne J; Dietz L; Vakalopoulos A; Haning P; Hartmann E; Seifert R; Hüser J; Mathar I; Sandner P
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy.
    Kuno A; Tanno M; Horio Y
    Ann N Y Acad Sci; 2015 Aug; 1348(1):46-54. PubMed ID: 26109180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy.
    Gordon BS; Delgado Díaz DC; Kostek MC
    Clin Nutr; 2013 Feb; 32(1):104-11. PubMed ID: 22795790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
    Capogrosso RF; Cozzoli A; Mantuano P; Camerino GM; Massari AM; Sblendorio VT; De Bellis M; Tamma R; Giustino A; Nico B; Montagnani M; De Luca A
    Pharmacol Res; 2016 Apr; 106():101-113. PubMed ID: 26930420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis.
    Ljubicic V; Burt M; Lunde JA; Jasmin BJ
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C66-82. PubMed ID: 24760981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin.
    Lecompte S; Abou-Samra M; Boursereau R; Noel L; Brichard SM
    Cell Mol Life Sci; 2017 Jul; 74(13):2487-2501. PubMed ID: 28188344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy.
    Ljubicic V; Jasmin BJ
    Trends Mol Med; 2013 Oct; 19(10):614-24. PubMed ID: 23891277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment?
    Sandri M; El Meslemani AH; Sandri C; Schjerling P; Vissing K; Andersen JL; Rossini K; Carraro U; Angelini C
    J Neuropathol Exp Neurol; 2001 Mar; 60(3):302-12. PubMed ID: 11245214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT1: A Novel Target for the Treatment of Muscular Dystrophies.
    Kuno A; Horio Y
    Oxid Med Cell Longev; 2016; 2016():6714686. PubMed ID: 27073590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophy.
    Chalkiadaki A; Igarashi M; Nasamu AS; Knezevic J; Guarente L
    PLoS Genet; 2014 Jul; 10(7):e1004490. PubMed ID: 25032964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy.
    Spreafico M; Cafora M; Bragato C; Capitanio D; Marasca F; Bodega B; De Palma C; Mora M; Gelfi C; Marozzi A; Pistocchi A
    Pharmacol Res; 2021 Aug; 170():105750. PubMed ID: 34214631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.
    Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic
    Wong TWY; Ahmed A; Yang G; Maino E; Steiman S; Hyatt E; Chan P; Lindsay K; Wong N; Golebiowski D; Schneider J; Delgado-Olguín P; Ivakine EA; Cohn RD
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32988972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
    Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
    Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.